Good find. You'd assume/hope that Paul has some figures to get some interest from the investors when doing a presentation like this. The pessimist in me worries that he is prepping the market for a capital raise. If they don't have any data to back it up then there is fat chance that they will get any. The optimist in me thinks there is no way they would go to an investor presentation without some positive news. I wonder as well what sort of information they are getting to do with anxiety treatment through this trial. Either way, we will soon know whether this 15-year-long journey is ending with a bang or a whimper.
AVE Price at posting:
0.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)